AI-generated summary
The authors randomized patients with oral lichen planus to photobiomodulation (660 nm) or topical clobetasol and assessed anxiety, depression, quality of life and cost-effectiveness. They report that anxiety and depression did not improve after either treatment, while both treatments improved quality of life, with corticoid being more cost-effective than photobiomodulation.
- Who or what was studied
- Patients with oral lichen planus
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The abstract does not state the total number of participants, and the cost-effectiveness and quality-of-life findings are based on the OHIP-14 questionnaire and a single comparison group design.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Energy density (fluence)
- 177 J/cm2
- Power
- 100mW
- Total energy
- 0.5 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Depression, Anxiety, Trial registration. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.